Physician profile
George Webb
NPI 1710945944
$30,889.85
in general payments reported to CMS, 2019-2025
20 companies · $910 in 2025
The $910 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,324 · 2020: $412 · 2021: $39.05 · 2022: $10K · 2023: $17K · 2024: $115 · 2025: $910.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $15K · Travel and Lodging: $1,456 · Food and Beverage: $843 · Education: $36.23.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $15,407.40 |
| Travel and Lodging | $1,456.29 |
| Food and Beverage | $842.67 |
| Education | $36.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $13,897.96 | 2019-2023 | Echelon Flex, Echelon Endopath, Echelon; Endopath |
| Ethicon INC. | $12,952.12 | 2022-2023 | Echelon Flex, Echelon Endopath, Echelon; Endopath |
| Intuitive Surgical, INC. | $2,269.34 | 2019-2024 | Da Vinci Surgical System |
| Ethicon US, LLC | $1,084.57 | 2019-2025 | Echelon Flex, Echelon Endopath, Echelon; Endopath |
| Abbvie INC. | $143.55 | 2023 | Strattice Reconstructive Tissue Matrix Bps |
| Tela Bio, INC. | $121.07 | 2022 | |
| Allergan, INC. | $119.55 | 2019 | |
| Merck Sharp & Dohme LLC | $37.83 | 2024 | Bridion |
| Axsome Therapeutics, INC. | $32.37 | 2025 | Symbravo |
| Smith+Nephew, INC. | $26.75 | 2025 | Renasys Touch |
| Shire North American Group INC | $26.48 | 2019 | |
| Acell, INC. | $26.13 | 2019 | |
| Davol INC. | $24.84 | 2022 | |
| Innocoll Pharmaceuticals Limited | $24.05 | 2022 | |
| Kerecis Limited | $23.95 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $17.09 | 2023 | Axonics |
| Biotissue Holdings INC. | $17.00 | 2021 | |
| Kci USA, INC. | $15.81 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $14.77 | 2024 | Exparel |
| Takeda Pharmaceuticals U.S.A., INC. | $14.62 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Webb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.